No, No, No, never mention capital raise again! The most recent...

No, No, No, never mention capital raise again! The most recent and prime example of why the current board/management team shouldn't be trusted with another cent stems from their late June update that interim DIPG data was due in July/August, this then slipped to September and what data did we get? An announcement that some data will be presented in Mid Nov. Given the length of time it has taken the AGILE team to present Regorafenib data it is a safe bet that the Paxalsib GBM data will be 'unexpectedly delayed', or we'll get an announcement that the data has been accepted for a conference in April '24 and we will be informed about it by Kazia on Dec 30th. So no let's get some positive DIPG data in mid Nov and sell it off for someone else to drive it to an NDA. More dilution to pay the salaries of folks that couldn't organize a chook raffle!! Friend be a mate get a deal done! On the other hand, IF the USA government ever gets its crap together on the PASTEUR act Recce would be mad not to move to the USA.